Assert-IQ vs uCT 780

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Abbott
VS
by United Imaging Healthcare

AI Verdict

These tools are adjacent in their application to cardiology diagnostics but serve distinct functions. Assert-IQ is an insertable cardiac monitor focused on long-term, continuous arrhythmia detection, while the uCT 780 is a CT imaging system designed for high-quality, low-dose anatomical scans, particularly for cardiac structures. Physicians would choose Assert-IQ for ongoing rhythm monitoring and the uCT 780 for detailed anatomical visualization.

Choose Assert-IQ if…

Choose Assert-IQ if your patient requires long-term, continuous cardiac monitoring to detect infrequent or asymptomatic arrhythmias that might be missed by conventional, shorter-term monitoring methods. This system is ideal for diagnosing conditions like unexplained syncope, cryptogenic stroke, or suspected atrial fibrillation, offering remote monitoring and patient-activated event logging for comprehensive data collection over several years.

View Assert-IQ →

Choose uCT 780 if…

Choose the uCT 780 if your diagnostic needs demand high-resolution, low-dose computed tomography, particularly for detailed cardiac or complex anatomical imaging. This 160-slice CT scanner excels in scenarios requiring rapid acquisition, advanced cardiac diagnostics with technologies like CardioXphase, and effective metal artifact correction, ensuring precise visualization for challenging cases.

View uCT 780 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Assert-IQ uCT 780
Deployment Subcutaneously implanted device with mobile app connectivity On-premise
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Assert-IQ

Assert-IQ focuses on patient comfort through minimally invasive insertion and empowers patients with a symptom logging activator. Its remote monitoring capabilities and cloud-based platform also streamline data access for clinicians, making it highly usable for continuous, long-term care.

Clinical Value

Assert-IQ

While both tools offer significant clinical value, Assert-IQ provides unique long-term, continuous cardiac monitoring for up to six years, which is crucial for diagnosing and managing intermittent arrhythmias that might otherwise be missed. This sustained data stream and proactive alerts offer a distinct advantage in ongoing patient management compared to a point-in-time diagnostic scan.

Pricing & Value

Tie

Both Assert-IQ and uCT 780 are high-value medical devices with enterprise-level pricing that is not publicly disclosed. Without specific cost information or detailed return on investment analyses for each, it is impossible to definitively determine which offers superior pricing or overall value.

Enterprise Readiness

Assert-IQ

Both tools are FDA cleared and HIPAA compliant, suitable for enterprise deployment. However, Assert-IQ's hybrid deployment model and explicit data export capabilities offer greater flexibility for integration into existing health system IT infrastructure and support modern distributed care models.

Innovation

uCT 780

The uCT 780 demonstrates significant innovation by integrating AI-powered workflows via its uAI Vision 3D camera and pushing boundaries in imaging hardware with features like the Z-Detector and CardioXphase. These advancements lead to superior image quality, speed, and dose reduction, particularly for complex cardiac scans.

Support & Docs

Assert-IQ

Abbott Medical, the company behind Assert-IQ, is a global healthcare leader with a history spanning over a century. This extensive experience and established presence strongly suggest a more mature, comprehensive, and globally distributed support infrastructure and documentation compared to United Imaging Healthcare.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Assert-IQ uCT 780
Name Assert-IQ uCT 780
Company Abbott Medical Shanghai United Imaging Healthcare Co.
Description The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. The uCT 780 is a 160-slice CT scanner from United Imaging Healthcare, integrating AI-powered workflows and advanced hardware for high-quality, low-dose imaging, particularly for cardiac and detailed anatomical scans. It is not an AI tool for a physician directory, but a medical imaging device.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Internal Medicine Cardiology, Interventional Radiology, Radiology
Key Features (partial) Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission 160-slice CT scanner, uAI Vision 3D camera for AI-empowered workflow, Z-Detector with 0.5 mm detector element size for fine detail and noise reduction

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and uCT 780.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Assert-IQu2122 is an insertable cardiac monitor designed for long-term, continuous monitoring and advanced arrhythmia detection to diagnose and manage suspected heart rhythm disorders. The uCT 780 is a 160-slice CT scanner that provides high-quality, low-dose imaging, specifically for cardiac and detailed anatomical scans.
Assert-IQu2122 is a minimally invasive, insertable device that continuously monitors heart rhythms for up to six years, transmitting data via Bluetoothu00ae Low Energy to a cloud-based platform. The uCT 780 is an on-premise medical imaging device that uses X-ray technology to generate detailed cross-sectional images with a 0.3s rotation speed and 150ms native temporal resolution.
Assert-IQu2122 uses advanced AI algorithms for arrhythmia detection, aiming to reduce false positives for AF and pause episodes while maintaining high sensitivity. The uCT 780 integrates AI-powered workflows through its uAI Vision 3D camera and features AI-driven technologies like KARL 3D denoising and DELTA deep learning reconstruction for enhanced image quality and dose reduction.
Assert-IQu2122 is primarily targeted at Cardiology and Internal Medicine specialties for the diagnosis and management of heart rhythm disorders. The uCT 780 is designed for Cardiology, Interventional Radiology, and Radiology, focusing on detailed anatomical and cardiac structural imaging.
Assert-IQu2122 offers minimally invasive insertion, remote monitoring capabilities, and a patient activator for symptom logging, allowing patients to go about daily life while being monitored. The uCT 780 emphasizes low-dose imaging with technologies like uDose and Auto ALARA kVp, and includes MAC (Metal Artifact Correction) for clear images with metal implants, enhancing patient safety and image quality.
AI Tool Finder
AI-powered search. Results may not be comprehensive.